Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism factor XIa inhibitors(factor XIa inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H18Br2N4O5 |
InChIKeyXFAYUCCPAGOBFN-UHFFFAOYSA-N |
CAS Registry1033617-31-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Preclinical | Australia | 30 May 2008 |